Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 280Thoracic 15Gastrointestinal 11Gynecologic 7Other 4Genitourinary 3Dermatologic 3CNS 3Breast 3Other neoplasm 2Sarcoma 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Precancerous Conditions 2Papillomavirus Infections 2Head and Neck Neoplasms 2Tongue Neoplasms 1Malignant Neoplasm of Colorectum 1Locally Advanced Malignant Neoplasm 1Gastric Adenocarcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 2Cisplatin 2Cetuximab 2vandetanib 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Immunohistochemistry 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Biopsy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Cisplatin × Other neoplasm × Clear all
NCT01302834 2026-01-12

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
987 enrolled 59 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Papillomavirus Infections

NCT01084083 2023-06-28

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
90 enrolled 7 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡